Hyperparathyroidism in chronic renal failure. 1977

S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan

The high circulating concentrations of immunoassayable parathyroid hormone observed in chronic renal failure are due to a number of factors. These include altered metabolism of the hormone and also end-organ unresponsiveness which may, indirectly, cause increased secretion of parathyroid hormone. The response of the overactive parathyroid glands to changes in plasma calcium and magnesium is variable and caution is needed in evaluating the suppressibility of parathyroid hormone secretion in acute studies. 1alpha-Hydroxylated derivatives of vitamin D can effectively suppress parathyroid gland overactivity. This effect may not necessarily be medicated through hypercalcaemia and vitamin D metabolites may act directly on the parathyroid glands.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
September 1970, Lancet (London, England),
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
January 1983, Scandinavian journal of urology and nephrology. Supplementum,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
January 1981, Annals of clinical and laboratory science,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
January 1972, Acta medica Iugoslavica,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
August 1983, Southern medical journal,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
May 1973, Urological research,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
December 1982, European journal of pediatrics,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
April 1995, Nihon rinsho. Japanese journal of clinical medicine,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
July 1970, The Quarterly journal of medicine,
S E Papapoulos, and A M Brownjohn, and B J Junor, and F P Marsh, and F J Goodwin, and W Hately, and I G Lewin, and S Tomlinson, and G N Hendy, and J L O'Riordan
August 1998, Nephron,
Copied contents to your clipboard!